Carregant...
The therapeutic monoclonal antibody market
Since the commercialization of the first therapeutic monoclonal antibody product in 1986, this class of biopharmaceutical products has grown significantly so that, as of November 10, 2014, forty-seven monoclonal antibody products have been approved in the US or Europe for the treatment of a variety...
Guardat en:
| Publicat a: | MAbs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622599/ https://ncbi.nlm.nih.gov/pubmed/25529996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2015.989042 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|